321 related articles for article (PubMed ID: 21173432)
1. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
3. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
4. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
5. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
[TBL] [Abstract][Full Text] [Related]
6. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
7. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
8. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
[TBL] [Abstract][Full Text] [Related]
9. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.
Murillo G; Peng X; Torres KE; Mehta RG
Cancer Prev Res (Phila); 2009 Nov; 2(11):942-50. PubMed ID: 19861542
[TBL] [Abstract][Full Text] [Related]
10. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
11. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
Saldanha G; Ghura V; Potter L; Fletcher A
Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
13. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
[TBL] [Abstract][Full Text] [Related]
15. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
Du Q; Zhang X; Liu Q; Zhang X; Bartels CE; Geller DA
Cancer Res; 2013 Nov; 73(21):6526-37. PubMed ID: 24008318
[TBL] [Abstract][Full Text] [Related]
18. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
19. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]